Controlled Release Auris Sensory Cell Modulator Compositions
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for otic disorders, such as ototoxicity and sensorineural hearing loss, face challenges due to systemic administration methods that result in uneven drug distribution, systemic toxicity, and adverse side effects, while existing formulations lack compatibility with the inner ear's unique environment and sterility requirements.
Innovation Solution
Development of controlled release compositions and formulations for auris sensory cell modulators that are specifically designed for local delivery to the middle and inner ear, using auris-acceptable excipients and vehicles to ensure sterility, compatibility, and reduced dosing frequency, incorporating agents like otoprotectants and trophic factors to promote cell growth or protection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If systemic administration methods are used to deliver therapeutic agents to the inner ear, then the drug can reach the target site, but uneven drug distribution and systemic toxicity occur
Solution Approach 1:
The invention segments the drug delivery system into local (inner ear) and systemic components by using controlled-release formulations that release therapeutic agents directly at the target site. This segmentation allows the drug to act locally without requiring high systemic concentrations, thereby reducing systemic toxicity while maintaining effective local drug levels.
Solution Approach 2:
The invention applies local quality by designing formulations with specific properties tailored for inner ear delivery, including auris-acceptable excipients and controlled-release mechanisms that maintain appropriate drug concentrations locally. This localized optimization ensures effective drug distribution within the inner ear while minimizing systemic exposure and associated toxicity.
2Ease of operation
If conventional formulations are used for inner ear delivery, then administration is straightforward, but compatibility with the inner ear's unique environment and sterility requirements are not met
Solution Approach 1:
The invention changes critical formulation parameters including pH, osmolarity, and sterility to match the unique environment of the inner ear. By adjusting these parameters, the formulation achieves both compatibility with inner ear physiology and ease of administration, resolving the contradiction between operational simplicity and formulation reliability.
3Reliability
If frequent dosing is used to maintain therapeutic levels, then drug efficacy is improved, but treatment complexity and patient burden increase
Solution Approach 1:
The invention implements continuous useful action through controlled-release formulations that gradually release therapeutic agents over extended periods. This continuous release mechanism maintains effective drug concentrations without requiring frequent dosing, thereby preserving drug efficacy while simplifying the treatment regimen and reducing patient burden.
Data Source
AI summary
Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with auris sensory cell modulating agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).